Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8315535 | Clinica Chimica Acta | 2012 | 6 Pages |
Abstract
⺠Significantly alterations of cellular immunity in NPC as compared with healthy group. ⺠Radiochemotherapy result in immunologic changes excepting CD3+ or CD25+ lymphocyte. ⺠Elevated CD44+ lymphocytes demonstrate lower DFS in NPC undergoing radiochemotherapy. ⺠CD44+ lymphocyte is a promising independent predictor of survival for NPC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Fu-Jun Hu, Ming-Hua Ge, Pei Li, Chang-Chun Wang, Yu-Tian Ling, Wei-Min Mao, Zhi-Qiang Ling,